Mason-based AssureRx has announced the largest commercial pilot program of its GeneSightRx test, which helps physicians select medications for individual patients with neuropsychiatric disorders by using a cheek swab to analyze genetic variants, reports the
Cincinnati Enquirer.
AssureRx is doing the program with Medco Research Institute LLC, a wholly owned subsidiary of Medco Health Solutions Inc
Read the full story
here.